65 studies reviewed: isolated testicular microlithiasis carries minimal cancer risk on its own — the company it keeps is what matters
Journal: Frontiers in Endocrinology | Published: 2026-04-15 | Type: Scoping Review | PMID: 42064772 Authors: Zhou Jiedong, Ouyang Yong, Hu Shian, Xiong Yuting, Liu Min (The First Affiliated Hospital of Gannan Medical University, Ganzhou, China) Funding/COI: Funding not disclosed. Authors declare no commercial or financial conflicts of interest.
Testicular microlithiasis (TM) — the small calcified deposits inside seminiferous tubules that show up as bright specks on ultrasound — has long spooked clinicians into aggressive surveillance because of a feared link to testicular germ cell tumors (TGCT). This scoping review of 65 studies argues that fear is misplaced when TM appears in isolation. The real risk signal emerges when TM co-occurs with established factors: cryptorchidism, infertility, or a family history of TGCT. The authors propose a risk-stratification framework — not as a clinical guideline, but as a hypothesis-generating scaffold to structure future research.
This is a scoping review — which means the authors mapped the breadth of evidence, not its quality. They explicitly did not perform formal risk-of-bias assessment or GRADE the certainty of evidence. That is methodologically appropriate for the stated goal (charting a heterogeneous field) but means no conclusions about treatment or surveillance effectiveness can be drawn with confidence. The PRISMA-ScR reporting guideline was followed. The search covered PubMed, Embase, and Web of Science from 2015–2025, yielding 1,110 records that narrowed to 65 included studies after screening; landmark pre-2015 studies were recovered through hand-searching.
The 65 included studies span observational designs (cohort, case-control), systematic reviews, clinical guidelines, and emerging technology evaluations — a heterogeneous mix that necessitated narrative synthesis. That heterogeneity is also the problem: without quantitative pooling or quality appraisal, the resulting framework rests on a foundation the authors themselves describe as "predominantly retrospective and observational."
This paper does one useful thing well: it argues, with appropriate caution, that isolated testicular microlithiasis should not trigger a cascade of surveillance imaging. That message pushes back against clinical overcaution and is consistent with major society guidelines. Beyond that, the framework it proposes is an organizing schema for future research, not a clinical protocol — and to the authors' credit, they say so. What they cannot hide is that the underpinning evidence is weak, heterogeneous, and devoid of RCTs. The molecular biology discussion is the most substantive section, but even there the review maps existing knowledge without generating new insight. Read it to understand why this field is messy; don't cite it as evidence that any specific management strategy works.